Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2005
10/19/2005EP1585517A1 Use of substituted 2-phenylbenzimidazoles as medicaments
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1070714A9 Amidine compounds
10/19/2005EP1058679B1 Synthesis of epothilones, intermediates thereto and analogues therof
10/19/2005CN1685014A Metal complexes as light-absorbing compounds in the information layer of optical data carriers
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684685A Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications
10/19/2005CN1683370A Hetaryl-substd. heterocycles
10/19/2005CN1223564C Intermediate halo phenyl derivatives and their use in process for preparing pyrrole derivatives
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005CA2295063C Indole compounds as anti-inflammatory/analgesic agents
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/13/2005WO2005095393A1 Oxidized thioether derivatives of styryl-azoles and their use as her tyrosine kinases inhibitors
10/13/2005WO2005095392A1 Silylated carboxamides
10/13/2005WO2005095391A1 Thiazoliums as transketolase inhibitors
10/13/2005WO2005095390A2 Novel co-precipitate of amorphous rosiglitazone
10/13/2005WO2005095386A1 Substituted thiophene derivatives as anti-cancer agents
10/13/2005WO2005095384A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/13/2005WO2005095382A1 Anti-tumor agent
10/13/2005WO2005095366A1 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3h)-one derivatives and their use as progesterone receptor modulators
10/13/2005WO2005095364A1 Phenoxyacetic acid derivative and medicine containing the same
10/13/2005WO2005095363A1 Bicyclic compound and medicine containing the same
10/13/2005WO2005095362A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
10/13/2005WO2005095361A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095360A1 Neurologically-active compounds
10/13/2005WO2005095359A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/13/2005WO2005095357A2 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005WO2005095345A2 Heteroaryl guanidines as inhibitors of viral replication
10/13/2005WO2005095342A1 Process for producing bipyridinium compound
10/13/2005WO2005095341A1 Nitrogen-containing heterocyclic compound
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005075468A3 Pyridinyl - or pyrimidinyl thiazoles with protein kinase inhibiting activity
10/13/2005WO2005067644A3 Conjugated small molecules
10/13/2005WO2005033288A3 Hedgehog pathway antagonists
10/13/2005WO2005023183A3 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005WO2004071447A9 Substituted azole derivatives as therapeutic agents
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228031 Tyrosine kinase inhibitors
10/13/2005US20050228029 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
10/13/2005US20050228025 Substituted oxindole derivatives as tyrosine kinase inhibitors
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228017 Novel anticancer compounds
10/13/2005US20050228000 of the coagulation cascade or contact activation system: thrombin, factor Xa, factor XIa, factor IXa, factor VIIa or plasma kallikrein; e.g. -(6-carbamimidoyl-1H-indol-3-ylmethyl)-4-methoxy-biphenyl-2-carboxylic acid; anticoagulant, antiinflammatory agent
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
10/13/2005US20050227989 Polycyclic thiazoles as potassium ion channel modulators
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227972 treating disorders of the cardiovascular system; adenosine receptor agonists/antagonists
10/13/2005US20050227970 3-Benzyl-2-(4-trifluoromethyl-3-pyridylcarbonyl)imino-4-thiazolidone; durability; low concentrations; good spectrum of action; insecticides; miticides; nematocides; helminths
10/13/2005US20050226811 Radioactive iodine-labeled compound
10/13/2005US20050225235 Materials for injecting or transporting holes and organic electroluminescence devices using the same
10/13/2005US20050224524 Aerosol
10/13/2005DE102004013528A1 New aza-heterocyclic spiro-cyclopropyl compounds, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents
10/13/2005DE102004010194A1 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln 4-benzimidazole-2-yl-pyridazin-3-one derivatives, their preparation and use in medicaments
10/13/2005CA2563038A1 Neurologically-active compounds
10/13/2005CA2562126A1 Pyrazine derivatives and pharmaceutical use thereof
10/13/2005CA2562106A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005CA2561977A1 Substituted thiophene derivatives as anti-cancer agents
10/13/2005CA2559957A1 Silylated carboxamides
10/13/2005CA2558915A1 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005CA2557393A1 Oxidized thioether derivatives of styryl-azoles and their use as her tyrosine kinases inhibitors
10/13/2005CA2557372A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/12/2005EP1584619A1 Derivatives of quinoline as inhibitors for MEK
10/12/2005EP1583763A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity
10/12/2005EP1583762A1 Pyrrolyl-thiazoles and their use as cb 1 receptor inverse agonists
10/12/2005EP1583760A2 Substituted heterocyclic compounds
10/12/2005EP1583757A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
10/12/2005EP1583752A2 Cyclization process for substituted benzothiazole derivatives
10/12/2005EP1583751A1 Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583743A1 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
10/12/2005EP1583532A1 Quinoline derivatives as glucokinase ligands
10/12/2005EP1583530A1 2-aminothiazole allosteric enhancers of a1-adenosine receptors
10/12/2005EP1583458A2 Lipophilic electrophoretic probes
10/12/2005EP1448196B1 Benzothiazole derivatives as adenosine receptor ligands
10/12/2005EP1194421B1 Selective npy (y5) antagonists
10/12/2005EP1177188B1 Pyrazole carboxamides useful for the treatment of obesity and other disorders
10/12/2005EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/12/2005EP0977563B1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10/12/2005EP0946170B1 Diclofenac for the treatment of vasculopathies
10/12/2005EP0912547B1 New substituted pyridyl keto enols
10/12/2005CN1681890A Process for preparing azo compound
10/12/2005CN1681812A Preparation of aztreonam
10/12/2005CN1681811A Azolidinone-vinyl fused-benzene derivatives
10/12/2005CN1681810A Novel oxazole and thiazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681809A Novel isothiazole and isoxazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681808A N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists useful for the treatment of diabetes
10/12/2005CN1681805A Novel imidazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681791A 8－羟基喹啉衍生物 8-hydroxyquinoline derivative
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681502A Novel triazole compounds as transforming growth factors (TGF) inhibitors
1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 628